Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05535933 |
| Consolidated Lead Sponsor | Hutchmed |
| Therapeutic Condition Cohort | Immunology, Rheumatology, and Dermatology |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 111 participants (ACTUAL) |
| Registered Start Date | 2022-09-30 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Fujian Medical University Union Hospital | Fuzhou, China | Open Hospital Dossier -> |
| Lanzhou University Second Hospital | Lanzhou, China | Open Hospital Dossier -> |
| Shenzhen Second People's Hospital | Shenzhen, China | Open Hospital Dossier -> |
| Hainan General Hospital | Haikou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.